Clinical Trials Sponsored by Mundipharma+AB

Total 1224 results

Xspray Pharma AB

Completed

Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Subjects

Pharmacokinetics | Bioavailability

United Kingdom
Calliditas Therapeutics AB

Active, not recruiting

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE) (Nefigard-OLE)

Primary IgA Nephropathy

Sweden
Calliditas Therapeutics AB

Completed

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy (Nefigard)

Primary IgA Nephropathy

United States, Australia, Taiwan, Spain, Canada, Argentina, Belarus, Belgium, Czechia, Finland, France, Germany, Greece, Italy, Korea, Republic of, Poland, Sweden, Turkey, United Kingdom
Vicore Pharma AB

Completed

A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers

Drug Interaction

Sweden
Oriflame Cosmetics AB

Completed

Facial Skin Clinical and Microbial Profiling From Oral Probiotic Supplementation

Healthy | Skin Manifestations

Sweden
Hansa Biopharma AB

Terminated

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

Kidney Transplant Rejection

Germany, France, Austria
Calliditas Therapeutics AB

Completed

Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects

Phase 1

France
Hansa Biopharma AB

Completed

A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test (Highdes)

Kidney Failure, Chronic

United States, Sweden, France
Athera Biotechnologies AB

Completed

Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction

ST Elevation Myocardial Infarction

Sweden
Galecto Biotech AB

Completed

A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects

Safety and Tolerability

United Kingdom
PepTonic Medical AB

Completed

Evaluation of VagiVital® for Treatment of Vaginal Atrophy

Vaginal Atrophy

Sweden
Isofol Medical AB

Completed

PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

Colonic Neoplasms

Sweden
Isofol Medical AB

Completed

Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.

Osteosarcoma

Poland, Czechia, Hungary, Sweden
Isofol Medical AB

Completed

An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer

Rectal Cancer

Sweden
Occlutech International AB

Completed

Occlutech Septal Occluder (Figulla Flex II) Study

Secundum Atrial Septal Defects
Natumin Pharma AB

Completed

Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis

Tinea Pedis

Sweden
Gedea Biotech AB

Completed

Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Sweden
Modus Therapeutics AB

Completed

Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin

Safety and Tolerability

United States
Corline Biomedical AB

Unknown

Heparinized Islets in Clinical Islet Transplantation

Type 1 Diabetes Mellitus

Sweden
AB Biotics, SA

Completed

A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia

Moderate Hypercholesterolemia

France
Vivolux AB
Theradex

Terminated

A Study of VLX1570 and Dexamethasone in Myeloma Patients

Multiple Myeloma

United States
Moberg Pharma AB

Completed

A Study of the Systemic Absorption of MOB015B

Onychomycosis

United States
Occlutech International AB

Completed

Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation (OLAAC)

Atrial Fibrillation

Germany, United Kingdom
RSPR Pharma AB

Completed

Safety and Efficacy of CRD007 in Adult Asthma Subjects

Asthma

Denmark, Poland, Bulgaria, United Kingdom
RSPR Pharma AB

Completed

RSPR-007 Mannitol Challenge Trial

Asthma

Denmark
Newron Sweden AB

Terminated

A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.

Parkinson's Disease

Sweden
RSPR Pharma AB

Completed

Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast

Healthy Volunteers
PepTonic Medical AB

Completed

A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin

Vaginal Atrophy

Sweden
Tigran Technologies AB

Completed

Reconstruction of Peri-implant Osseous Defects: A Randomized Trial

Peri-implantitis

Sweden
Moberg Pharma AB

Completed

An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

Distal Subungual Onychomycosis

Sweden
Active Biotech AB

Completed

ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, Denmark, Russian Federation
Axcentua Pharmaceuticals AB

Unknown

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Adenocarcinoma

Sweden
Swedish Match AB

Completed

Serbian Smoking Reduction/Cessation Trial (2SRT) (2SRT)

Cigarette Smoking

Serbia
Moberg Pharma AB

Completed

Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head

Actinic Keratosis

Germany
RSPR Pharma AB

Completed

CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

Duchenne Muscular Dystrophy | Becker Muscular Dystrophy

Sweden
Moberg Pharma AB

Completed

A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects (Limsafe)

Healthy

Germany
Akloma Bioscience AB

Completed

The Akloma Tinnitus Patch in Patients With Manifested Tinnitus (Aktin)

Tinnitus

Sweden
PepTonic Medical AB

Completed

Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women

Vaginal Atrophy | Postmenopause

Sweden, United Kingdom
Diamyd Therapeutics AB

Completed

Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)

Latent Autoimmune Diabetes in Adult (LADA)

Sweden
Moberg Pharma AB

Completed

Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study

Atopic Dermatitis

Germany
Karo Bio AB

Completed

LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin

Dyslipidemia

Sweden
Karo Bio AB

Completed

LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe

Hypercholesterolemia

Sweden
Karo Bio AB

Completed

Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Sweden
Karolinska Institutet
Vastra Gotaland Region; SOS Alarm Sverige AB; Everdrone AB; Aviation capacity resources... and other collaborators

Completed

AED-delivery Using Drones in Suspected OHCA

Out-Of-Hospital Cardiac Arrest

Sweden
Spago Nanomedical AB

Recruiting

A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer (Tumorad)

Solid Tumor | Metastatic Cancer | Refractory Cancer | Locally Advanced Solid Tumor | Unresectable Solid Tumor | Recurrent Solid Tumor

Australia
Sigrid Therapeutics AB

Recruiting

Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® (SHINE)

Overweight or Obesity

Slovakia, Poland, Romania
Circius Pharma AB

Recruiting

Performance and Safety of Otinova® Ear Spray

Otitis Externa

Sweden
Occlutech International AB

Recruiting

PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

Patent Ductus Arteriosus

Tunisia, Turkey, Italy, Pakistan, United Kingdom
Occlutech International AB

Recruiting

ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices

Heart Diseases

Turkey, Germany
Occlutech International AB

Recruiting

Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion (OCCLUFLEX)

Stroke | Patent Foramen Ovale

United States, Denmark, Canada, Netherlands, Germany, United Kingdom, Finland

3

Subscribe